Search

Author/Creator Bexell, Daniel

1. Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma. Issue 1 (9th January 2020)

Authors:
Mohlin, Sofie; Hansson, Karin; Radke, Katarzyna; Martinez, Sonia; Blanco‐Aparicio, Carmen; Garcia‐Ruiz, Cristian; Welinder, Charlotte; Esfandyari, Javanshir; O'Neill, Michael; Pastor, Joaquin; von Stedingk, Kristoffer; Bexell, Daniel
Journal:
EMBO molecular medicine
Issue:
Volume 12:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy. (31st December 2023)

Authors:
Valind, Anders; Verhoeven, Bronte Manouk; Enoksson, Jens; Karlsson, Jenny; Christensson, Gustav; Mañas, Adriana; Aaltonen, Kristina; Jansson, Caroline; Bexell, Daniel; Baryawno, Ninib; Gisselsson, David; Hagerling, Catharina
Journal:
Oncoimmunology
Issue:
Volume 12:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours. Issue 2 (1st June 2016)

Authors:
Braekeveldt, Noémie; Wigerup, Caroline; Tadeo, Irene; Beckman, Siv; Sandén, Caroline; Jönsson, Jimmie; Erjefält, Jonas S.; Berbegall, Ana P.; Börjesson, Anna; Backman, Torbjörn; Øra, Ingrid; Navarro, Samuel; Noguera, Rosa; Gisselsson, David; Påhlman, Sven; Bexell, Daniel
Journal:
Cancer letters
Issue:
Volume 375:Issue 2(2016)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Neuroblastoma patient‐derived orthotopic xenografts retain metastatic patterns and geno‐ and phenotypes of patient tumours. Issue 5 (7th October 2014)

Authors:
Braekeveldt, Noémie; Wigerup, Caroline; Gisselsson, David; Mohlin, Sofie; Merselius, My; Beckman, Siv; Jonson, Tord; Börjesson, Anna; Backman, Torbjörn; Tadeo, Irene; Berbegall, Ana P.; Öra, Ingrid; Navarro, Samuel; Noguera, Rosa; Påhlman, Sven; Bexell, Daniel
Journal:
International journal of cancer
Issue:
Volume 136:Issue 5(2015:Mar. 01)
Page Start:
E252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PDTM-43. THERAPEUTIC TARGETS FROM BIG DATA: INTEGRATIVE DISCOVERY OF TREATMENTS FOR HIGH-RISK NEUROBLASTOMA. (11th November 2019)

Authors:
Almstedt, Elin; Wärn, Caroline; Elgendy, Ramy; Hekmati, Neda; Rosén, Emil; Larsson, Ida; Påhlman, Sven; Bexell, Daniel; Vanlandewijck, Michael; Jörnsten, Rebecka; Krona, Cecilia; Nelander, Sven
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis. Issue 1 (29th November 2018)

Authors:
Holmquist Mengelbier, Linda; Lindell‐Munther, Simon; Yasui, Hiroaki; Jansson, Caroline; Esfandyari, Javanshir; Karlsson, Jenny; Lau, Kimberly; Hui, Chi‐chung; Bexell, Daniel; Hopyan, Sevan; Gisselsson, David
Journal:
Journal of pathology
Issue:
Volume 247:Issue 1(2019)
Page Start:
86
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗